APR May/June 2022 - 4
IN THIS ISSUE
10 BIOPHARMACEUTICALS
Long-Acting Injectable Suspensions
René Holm
University of Southern Denmark
Department of Physics, Chemistry and Pharmacy
18 ROUNDTABLE
Controlled Release
30 FORMULATION AND DEVELOPMENT
The Promise and Challenges of mRNA Vaccine Development
Robert Dream
HDR Company LLC
36 DRUG DELIVERY
Introduction to mRNA-LNPs, Their Manufacture and Future Perspectives
Dr. Philip M E Probert, Head of Technical
Dr. Juliana M Haggerty, Head of LNP Centre of Excellence
Dr. John M Liddell, Chief Technologist
Mr. Graham Worrall, Chief Technologist
Centre for Process Innovation, UK
42 BIOPHARMACEUTICALS
A Next-Generation Workforce for Next- Generation Therapies Preparing
for Cell and Gene Therapies
Emily Moran, Vice President, Viral Vector Manufacturing
The Center for Breakthrough Medicines (CBM)
60 FACILITY TOUR
Growing to Serve: Eurofins' Portage, Michigan, Facility Expands to Offer
New Capabilities and Services
80 MICROBIOLOGY
Cleaning and Disinfection: An Important Pillar of Contamination Control
Ratul Saha, PhD, Director, Contamination Control
Seres Therapeutics
»
QC CORNER
28 Affinity Approaches to Selective, Sensitive MS Assays
Sponsored Content from MilliporeSigma
VENDOR VIEWPOINTS
63 Combining the Best of Both Worlds with
Semi-Targeted Metabolomics
Bashar Amer, Metabolomics Application Development
Thermo Fisher Scientific
66 Method Changes for Bacterial Endotoxins Testing (BET): Steps to
Follow for a Straightforward Process
Hayden Skalski
SUEZ Water Technologies
REGULAR FEATURES
6 Message from the Editor
7 Editorial Advisory Board
68
70 Editor's Top Tech
79 Equipment Focus
86 P.I.N. Points
88 Advertiser's Index
SPECIAL FEATURES
8 CN Perspectives
9
An Interview with Tony Saavedra
Sievers DataShare Elite Stoftware
Social Media Connections
4 |
| May/June 2022
APR May/June 2022
Table of Contents for the Digital Edition of APR May/June 2022
Message from the Editor
Editorial Advisory Board
CN Perspectives
Social Media Connections
BIOPHARMACEUTICALS - Long-Acting Injectable Suspensions
ROUNDTABLE - Controlled Release
QC CORNER - Affinity Approaches to Selective, Sensitive MS Assays
DRUG DELIVERY - Introduction to mRNA-LNPs, Their Manufacture and Future Perspectives
BIOPHARMACEUTICALS - A Next-Generation Workforce for Next- Generation Therapies Preparing for Cell and Gene Therapies
MICROBIOLOGY - Optimizing a Viral Testing Strategy
BIOPHARMACEUTICAL - Assuring Quality of Oligonucleotide APIs and DPs
FACILITY TOUR - Growing to Serve: Eurofins’ Portage, Michigan, Facility Expands to Offer New Capabilities and Services
VENDOR VIEWPOINT - Combining the Best of Both Worlds with Semi-Targeted Metabolomics
VENDOR VIEWPOINT - Method Changes for Bacterial Endotoxins Testing (BET): Steps to Follow for a Straightforward Process
An Interview with Tony Saavedra Sievers DataShare Elite Stoftware
Editor's Top Tech
MANUFACTURING - A Discourse on Pharmaceutical cGMP FDA Form 483 Trends: Why are We Re-Living the Same Issues Over the Last 23 Years?
Equipment Focus
MICROBIOLOGY - Cleaning and Disinfection: An Important Pillar of Contamination Control
P.I.N. Points
Advertiser's Index
APR May/June 2022 - Cover1
APR May/June 2022 - Cover2
APR May/June 2022 - 1
APR May/June 2022 - 2
APR May/June 2022 - 3
APR May/June 2022 - 4
APR May/June 2022 - 5
APR May/June 2022 - Message from the Editor
APR May/June 2022 - Editorial Advisory Board
APR May/June 2022 - CN Perspectives
APR May/June 2022 - Social Media Connections
APR May/June 2022 - BIOPHARMACEUTICALS - Long-Acting Injectable Suspensions
APR May/June 2022 - 11
APR May/June 2022 - 12
APR May/June 2022 - 13
APR May/June 2022 - 14
APR May/June 2022 - 15
APR May/June 2022 - 16
APR May/June 2022 - 17
APR May/June 2022 - ROUNDTABLE - Controlled Release
APR May/June 2022 - 19
APR May/June 2022 - 20
APR May/June 2022 - 21
APR May/June 2022 - 22
APR May/June 2022 - 23
APR May/June 2022 - 24
APR May/June 2022 - 25
APR May/June 2022 - 26
APR May/June 2022 - 27
APR May/June 2022 - QC CORNER - Affinity Approaches to Selective, Sensitive MS Assays
APR May/June 2022 - 29
APR May/June 2022 - 30
APR May/June 2022 - 31
APR May/June 2022 - 32
APR May/June 2022 - 33
APR May/June 2022 - 34
APR May/June 2022 - 35
APR May/June 2022 - DRUG DELIVERY - Introduction to mRNA-LNPs, Their Manufacture and Future Perspectives
APR May/June 2022 - 37
APR May/June 2022 - 38
APR May/June 2022 - 39
APR May/June 2022 - 40
APR May/June 2022 - 41
APR May/June 2022 - BIOPHARMACEUTICALS - A Next-Generation Workforce for Next- Generation Therapies Preparing for Cell and Gene Therapies
APR May/June 2022 - 43
APR May/June 2022 - 44
APR May/June 2022 - 45
APR May/June 2022 - MICROBIOLOGY - Optimizing a Viral Testing Strategy
APR May/June 2022 - 47
APR May/June 2022 - 48
APR May/June 2022 - 49
APR May/June 2022 - 50
APR May/June 2022 - 51
APR May/June 2022 - BIOPHARMACEUTICAL - Assuring Quality of Oligonucleotide APIs and DPs
APR May/June 2022 - 53
APR May/June 2022 - 54
APR May/June 2022 - 55
APR May/June 2022 - 56
APR May/June 2022 - 57
APR May/June 2022 - 58
APR May/June 2022 - 59
APR May/June 2022 - FACILITY TOUR - Growing to Serve: Eurofins’ Portage, Michigan, Facility Expands to Offer New Capabilities and Services
APR May/June 2022 - 61
APR May/June 2022 - 62
APR May/June 2022 - VENDOR VIEWPOINT - Combining the Best of Both Worlds with Semi-Targeted Metabolomics
APR May/June 2022 - 64
APR May/June 2022 - 65
APR May/June 2022 - VENDOR VIEWPOINT - Method Changes for Bacterial Endotoxins Testing (BET): Steps to Follow for a Straightforward Process
APR May/June 2022 - 67
APR May/June 2022 - An Interview with Tony Saavedra Sievers DataShare Elite Stoftware
APR May/June 2022 - 69
APR May/June 2022 - Editor's Top Tech
APR May/June 2022 - 71
APR May/June 2022 - MANUFACTURING - A Discourse on Pharmaceutical cGMP FDA Form 483 Trends: Why are We Re-Living the Same Issues Over the Last 23 Years?
APR May/June 2022 - 73
APR May/June 2022 - 74
APR May/June 2022 - 75
APR May/June 2022 - 76
APR May/June 2022 - 77
APR May/June 2022 - 78
APR May/June 2022 - Equipment Focus
APR May/June 2022 - MICROBIOLOGY - Cleaning and Disinfection: An Important Pillar of Contamination Control
APR May/June 2022 - 81
APR May/June 2022 - 82
APR May/June 2022 - 83
APR May/June 2022 - 84
APR May/June 2022 - 85
APR May/June 2022 - P.I.N. Points
APR May/June 2022 - 87
APR May/June 2022 - Advertiser's Index
APR May/June 2022 - Cover3
APR May/June 2022 - Cover4
https://www.nxtbookmedia.com